Expansion explosion: new clues to the pathogenesis of repeat expansion neurodegenerative diseases (Q45304560)

11 December 2017

Expansion explosion: new clues to the pathogenesis of repeat expansion neurodegenerative diseases (English)

1 reference

11 December 2017

1 reference

Margolis RL

1

1 reference

PubMed ID

11689312

11 December 2017

Ross CA

series ordinal

2

1 reference

11 December 2017

1 November 2001

1 reference

Trends in Molecular Medicine

11 December 2017

1 reference

11 December 2017

7

1 reference

11 December 2017

11

1 reference

11 December 2017

479-482

1 reference

The human gene mutation database

11 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

Biological implications of the DNA structures associated with disease-causing triplet repeats

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

When more is less: pathogenesis of glutamine repeat neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

Expanding our understanding of polyglutamine diseases through mouse models

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

Identification of genes that modify ataxin-1-induced neurodegeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

New light on polyglutamine neurodegenerative disorders: interference with transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

Impairment of the ubiquitin-proteasome system by protein aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

Energetics in the pathogenesis of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8)

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

Expansion of a novel CAG trinucleotide repeat in the 5' region of PPP2R2B is associated with SCA12.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

Altered spacing of promoter elements due to the dodecamer repeat expansion contributes to reduced expression of the cystatin B gene in EPM1.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902179-7

7 January 2021

10.1016/S1471-4914(01)02179-7

Identifiers

DOI

1 reference

11 December 2017

1 reference

PubMed ID

11689312